Jahanafrooz et al. Page 17 Table 1 - DNA vs. mRNA Cancer Vaccines
29 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is a common extracellular barrier for both DNA and mRNA cancer vaccines?

  • Serum nucleases (correct)
  • Endocytosis
  • Nuclear membrane
  • Cell membrane
  • How do DNA and mRNA vaccines differ in terms of cellular uptake mechanisms?

  • Through caveolae and/or lipid rafts (correct)
  • Temperature and dose dependent
  • Endosomal pathway to reach cytosol
  • Macropinocytosis
  • Which factor is a specific intracellular barrier for DNA vaccines but not mRNA vaccines?

  • Entrance to nucleus by nuclear localization signal sequences
  • Cellular uptake of naked NAVs mechanisms (correct)
  • Nucleases (RNase)
  • Nuclear membrane
  • What is a shared trait between DNA and mRNA cancer vaccines in terms of endosomal pathways?

    <p>Endocytosis</p> Signup and view all the answers

    In terms of intracellular barriers, what is unique to mRNA vaccines compared to DNA vaccines?

    <p>Nucleases (DNase)</p> Signup and view all the answers

    What is one of the strategies mentioned in the text for the success of anticancer nucleic acid vaccines (NAV)?

    <p>Small-molecule targeting of inflammatory signaling cascades</p> Signup and view all the answers

    Which grant supported M.R.H. according to the text?

    <p>R01AI050875</p> Signup and view all the answers

    In the context of cancer immunotherapy, what is emphasized for personalization and efficacy?

    <p>Combinatorial approaches</p> Signup and view all the answers

    What is NOT mentioned as a strategy for next-generation cancer treatment?

    <p>Immunotherapy using T cells</p> Signup and view all the answers

    Which journal article discusses the past, present, and future of therapeutic cancer vaccines?

    <p>Guo C et al.(2013)</p> Signup and view all the answers

    Which type of vaccines are discussed in the article by Rezaei T et al. (2019)?

    <p>HIV DNA vaccines</p> Signup and view all the answers

    What are some challenges to the viability of NAVs as alternatives to peptide vaccines?

    <p>Choosing the right TAs, insufficient immunogenicity, and the immunosuppressive nature of cancer</p> Signup and view all the answers

    Which of the following is NOT mentioned as a characteristic that requires individual optimization for DNA and mRNA cancer vaccines?

    <p>Manufacturing process</p> Signup and view all the answers

    Who are the corresponding authors of this review?

    <p>A. Mokhtarzadeh and M.R. Hamblin</p> Signup and view all the answers

    What does the publisher's disclaimer mention about the provided manuscript?

    <p>It is an unedited version awaiting publication.</p> Signup and view all the answers

    Which conflict of interest does M.R. Hamblin declare?

    <p>None declared</p> Signup and view all the answers

    What is the main focus of the approaches discussed in the review related to anticancer NAVs?

    <p>Improving the efficiency of anticancer NAVs</p> Signup and view all the answers

    Where are the final destinations for encoded antigens?

    <p>Spleen and lymph nodes</p> Signup and view all the answers

    What is the role of APCs in presenting antigens to T and B cells?

    <p>Presenting epitopes</p> Signup and view all the answers

    In what type of organs are resident B and T cells activated by APCs?

    <p>Spleen and lymph nodes</p> Signup and view all the answers

    What process removes impurities and dsRNAs in mRNA vaccines?

    <p>Purification techniques</p> Signup and view all the answers

    Which type of vaccine requires only crossing the cell membrane for efficacy?

    <p>mRNA vaccines</p> Signup and view all the answers

    What contributes to the general low immunogenicity of DNA vaccines?

    <p>Poor translation of preclinical results to clinical trials</p> Signup and view all the answers

    What type of vaccine was studied by Yuan J et al. in patients with malignant melanoma?

    <p>Xenogeneic tyrosinase DNA vaccine</p> Signup and view all the answers

    Which publication discussed RNAi-based therapeutic strategies for metabolic disease?

    <p>Czech MP et al. (2011)</p> Signup and view all the answers

    In the context of DNA vaccines, what was the focus of the study by Hobernik D and Bros M in 2018?

    <p>Clinical use of DNA vaccines</p> Signup and view all the answers

    What was the subject of the study conducted by Kim SB et al. in 2015 related to patients with HER2-expressing breast cancer?

    <p>Truncated HER2 sequence vaccine</p> Signup and view all the answers

    Which study examined the delivery of neoantigen vaccines for personalized anticancer immunotherapy?

    <p>Guo Y et al. (2018)</p> Signup and view all the answers

    Regarding small molecules targeting the immunological tumor microenvironment, which publication discussed this topic?

    <p>Buqué A et al. (2016)</p> Signup and view all the answers

    More Like This

    Use Quizgecko on...
    Browser
    Browser